NASDAQ:GBIO Generation Bio Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Generation Bio Co. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $30.11 +2.73 (+9.97 %) (As of 09/25/2020 12:00 AM ET) Add Compare Share Today's Range$27.31Now: $30.11▼$30.4050-Day Range$19.30MA: $25.90▼$31.8452-Week Range$17.00Now: $30.11▼$32.18Volume222,012 shsAverage Volume206,637 shsMarket Capitalization$1.40 billionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsChartCompetitorsEarningsInsider TradesInstitutional OwnershipHeadlinesSocial Media Generation Bio Co. develops gene therapies for the treatment of genetic diseases. It focuses in the areas of liver, eye, muscle, and brain disorders. Generation Bio Co. was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. The company was founded in 2016 and is based in Cambridge, Massachusetts.Read More Beat the Market (BTM) Rank™ 1.5 Analyst's Opinion Consensus RatingGeneration Bio has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $32.33, Generation Bio has a forecasted upside of 7.4% from its current price of $30.11.Amount of Analyst CoverageGeneration Bio has only been the subject of 4 research reports in the past 90 days. Previous Next 4.0 Community Rank Outperform VotesGeneration Bio has received 4 “outperform” votes. (Add your “outperform” vote.)Underperform VotesGeneration Bio has received 1 “underperform” votes. (Add your “underperform” vote.)Community SentimentGeneration Bio has received 80.00% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Generation Bio and other stocks. Vote “Outperform” if you believe GBIO will outperform the S&P 500 over the long term. Vote “Underperform” if you believe GBIO will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldGeneration Bio does not currently pay a dividend.Dividend GrowthGeneration Bio does not have a long track record of dividend growth. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Generation Bio insiders have not sold or bought any company stock.Percentage Held by Institutions61.08% of the stock of Generation Bio is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Generation Bio are expected to grow in the coming year, from ($2.76) to ($2.35) per share. Previous Next Analyst Opinion: 1.5Community Rank: 4.0Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.43 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:GBIO Previous Symbol CUSIPN/A CIKN/A Webgenerationbio.com Phone857-529-5908Debt Debt-to-Equity RatioN/A Current Ratio26.54 Quick Ratio26.54Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees85 Outstanding Shares46,428,000Market Cap$1.40 billion Next Earnings Date11/10/2020 (Estimated) OptionableNot Optionable $30.11 +2.73 (+9.97 %) (As of 09/25/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive GBIO News and Ratings via Email Sign-up to receive the latest news and ratings for GBIO and its competitors with MarketBeat's FREE daily newsletter. Generation Bio (NASDAQ:GBIO) Frequently Asked Questions Do Wall Street analysts recommend investors buy shares of Generation Bio? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Generation Bio in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Generation Bio. When is Generation Bio's next earnings date? Generation Bio is scheduled to release its next quarterly earnings announcement on Tuesday, November 10th 2020. View our earnings forecast for Generation Bio. How were Generation Bio's earnings last quarter? Generation Bio Co. (NASDAQ:GBIO) announced its quarterly earnings data on Tuesday, August, 11th. The company reported ($1.50) EPS for the quarter, missing the Zacks' consensus estimate of ($0.60) by $0.90. View Generation Bio's earnings history. What price target have analysts set for GBIO? 4 analysts have issued 1 year target prices for Generation Bio's shares. Their forecasts range from $28.00 to $38.00. On average, they expect Generation Bio's share price to reach $32.33 in the next twelve months. This suggests a possible upside of 7.4% from the stock's current price. View analysts' price targets for Generation Bio. Who are some of Generation Bio's key competitors? Some companies that are related to Generation Bio include Bausch Health Companies (BHC), Emergent Biosolutions (EBS), Ultragenyx Pharmaceutical (RARE), Blueprint Medicines (BPMC), Zai Lab (ZLAB), Arrowhead Pharmaceuticals (ARWR), BridgeBio Pharma (BBIO), United Therapeutics (UTHR), HUTCHISON CHINA/S (HCM), Arena Pharmaceuticals (ARNA), MorphoSys (MOR), Evotec (EVTCY), Legend Biotech (LEGN), Allakos (ALLK) and FibroGen (FGEN). View all competitors. What other stocks do shareholders of Generation Bio own? Based on aggregate information from My MarketBeat watchlists, some companies that other Generation Bio investors own include Docusign (DOCU), NVIDIA (NVDA), Overstock.com (OSTK), Boeing (BA), Pure Storage (PSTG), Mastercard (MA), QUALCOMM (QCOM), Riot Blockchain (RIOT), Twilio (TWLO) and Enphase Energy (ENPH). Who are Generation Bio's key executives? Generation Bio's management team includes the following people: Dr. Cameron Geoffrey McDonough, Pres, CEO, Sec. & Director (Age 50, Pay $592.9k)Dr. Douglas Kerr M.B.A., M.D., Ph.D., Chief Devel. Officer (Age 53, Pay $534.69k)Dr. Mark D. Angelino Ph.D., Founder & COO (Age 47)Dr. Robert Kotin, Founder & Advisor (Age 64)Mr. Stephen J. DiPalma M.B.A., Interim Chief Financial Officer (Age 61) When did Generation Bio IPO? (GBIO) raised $126 million in an initial public offering (IPO) on Friday, June 12th 2020. The company issued 7,400,000 shares at $16.00-$18.00 per share. J.P. Morgan, Jefferies and Cowen served as the underwriters for the IPO and Wedbush PacGrow was co-manager. What is Generation Bio's stock symbol? Generation Bio trades on the NASDAQ under the ticker symbol "GBIO." When does the company's lock-up period expire? Generation Bio's lock-up period expires on Wednesday, December 9th. Generation Bio had issued 10,500,000 shares in its public offering on June 12th. The total size of the offering was $199,500,000 based on an initial share price of $19.00. After the expiration of the company's lock-up period, major shareholders and company insiders will be able to sell their shares of the company. Who are Generation Bio's major shareholders? Generation Bio's stock is owned by a variety of retail and institutional investors. Top institutional investors include FMR LLC (15.88%), FMR LLC (15.53%), Artal Group S.A. (6.31%), Bellevue Group AG (3.23%), Deerfield Management Company L.P. Series C (2.55%) and Victory Capital Management Inc. (1.90%). View institutional ownership trends for Generation Bio. Which major investors are buying Generation Bio stock? GBIO stock was acquired by a variety of institutional investors in the last quarter, including FMR LLC, FMR LLC, Artal Group S.A., Bellevue Group AG, Deerfield Management Company L.P. Series C, Victory Capital Management Inc., Harvard Management Co. Inc., and Logos Global Management LP. View insider buying and selling activity for Generation Bio. How do I buy shares of Generation Bio? Shares of GBIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Generation Bio's stock price today? One share of GBIO stock can currently be purchased for approximately $30.11. How big of a company is Generation Bio? Generation Bio has a market capitalization of $1.40 billion. Generation Bio employs 85 workers across the globe. What is Generation Bio's official website? The official website for Generation Bio is generationbio.com. How can I contact Generation Bio? Generation Bio's mailing address is 301 BINNEY STREET, CAMBRIDGE MA, 02142. The company can be reached via phone at 857-529-5908 or via email at [email protected] This page was last updated on 9/26/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
